Closing Bell: Hls Therapeutics Inc flat on Wednesday (HLS)

Hls Therapeutics Inc opened trading today at $3.47 and closed at $3.45. It traded at a low of $3.45 to a high of $3.47.

Shares $verbed percentage_change% from the previous day's close of $3.45.

During the day across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 2,125 shares was traded during the last trading day, with total trades of 7, while having an average volume of 1,866 in the last five days.

Trading across the entire TSX saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.77 (July 18,2023) and low as $3.25 (July 02,2024). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have shrunken -49.19%, while they have decreased -12.66% year-to-date.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $109.76 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..